GSK vs JTAI · P/E 13, $103.31B cap vs P/E 0.2, rev $7.0M
GlaxoSmithKline PLC ADR (GSK) versus Jet.AI Inc. (JTAI) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Jet.AI Inc. (JTAI) is a software - application company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported JTAI revenue for 2026-06-30 was $7.0M. Net income was -$5.0M. JTAI currently screens at market cap $8.9M and trailing P/E 0.2.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. JTAI currently screens at market cap $8.9M and trailing P/E 0.2.
Not investment advice. Open the GSK and JTAI stock pages for the full models.
Not investment advice.